NWPF

News ArchivesRead News

Beauty treatment gives relief to Parkinson’s patients

Thursday April 29, 2010

Health News - One of the world’s most fashionable beauty treatments is gaining popularity for something other than the war on wrinkles.

Botulinum Toxin, commonly known as Botox, is being used at the Muhammad Ali Parkinson Centre (MAPC) at Barrow Neurological Institute to help manage symptoms associated with Parkinson’s disease and other movement disorders.

“Botox is the most powerful nerve toxin known to man and it’s dramatically improving the quality of life for people with Parkinson’s,” says Guillermo Moguel-Cobos, movement disorder neurologist at the Centre. “For this type of treatment, it’s a miracle drug.”

Parkinson’s disease is characterised by muscle rigidity, tremors, a slowing of physical movement and a loss of physical movement.

Botox, which has been purified and then diluted, can be injectedstraight into the muscle, relieving the spasms and most importantly, the pain.

“It’s a medical treatment but it’s also an art to administer. Every patient receives Botox differently in different muscles, in different locations and in different dosages, so experience with the drug and the disease is crucial,” says Moguel-Cobos.

MAPC has been using Botox to treat Parkinson’s and other movement disorders such as dystonia since the early 1990s.

The treatment has recently gained popularity due to the growing number of patients at the MAPC. Out of approximately 1,600 patient visits each year, 30 percent receive Botox injections.

To help with the demand, the Centre runs a Botox Clinic two days a week. Depending on the patient and the severity of their movement disorder, their Botox can take 30 minutes to an hour to inject and can take up to seven days to become effective.

For most, the drug will provide significant but variable relief of symptoms that can last up to three months, says a release from the Barrow Neurological Institute.

Recent News

May 20 - Book Review: Aging in the Key of Humor
May 19 - Press Release: The Michael J. Fox Foundation for Parkinson's Research Joins Multinational Critical Path for Parkinson's Consortium
May 19 - Congress reaches deal to overhaul chemical regulation
May 16 - Lifestyle: Why Parkinson's disease won't stop me rowing across the Pacific
May 16 - Many biomarkers for PD fail to inform on progression
May 10 - Parkinson's Cell Transplant Shows Good Reinnervation at 24 Years
May 7 - Growing art installation gathers stories of living with Parkinson's
May 5 - New technique can provide better cell transplants against Parkinson's disease
May 2 - What's Good For The Heart Is Good For The Brain
Apr 29 - Press Release: FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease
Apr 28 - Dopamine-making neurons can be chemically controlled in animal model of Parkinson's
Apr 25 - Lifestyle: Dating with Disease
Apr 25 - Scientific breakthrough in fight against Parkinson's and Alzheimer's
Apr 20 - Breakthrough Parkinson's disease blood test
Apr 15 - Living with Parkinson's
Apr 12 - Tissue biomarker for dementia with Lewy bodies and Parkinson’s disease
Apr 11 - Yoga for Every Body: Experts say yoga can ease pain and improve mobility for people with neurologic conditions
Apr 9 - Commonly prescribed Parkinson's drugs up risk of compulsive gambling, shopping, binge eating, hypersexuality
Apr 7 - Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care
Apr 7 - Parkinson's Drug Highly Effective for Resistant Depression